Profile
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Company Name Rapport Therapeutics, Inc. Common Stock American Funds American Balanced 529A Merrill Lynch Capital Trust I GTD CAP 6.45% American Funds Invmt Co of Amer 529A American Funds Invmt Co of Amer F3 NextEra Energy, Inc. Series N J
Sector - - - - - -
Industry - - - - - -
Market Cap $310.95M $241.49B $202.04B $156.29B $156.29B $144.51B
Employees 0.07K 0.00K 0.00K 0.00K 0.00K 0.00K
CEO Mr. Abraham N. Ceesay M.B.A. - - - - -
Ratings
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Quant Rating Score 2 4 3
Quant Rating Sell Buy Neutral
Trading
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Last Close $8.52 $33.42 $25.59 $53.56 $53.73 $22.69
High 52 $29.23 $37.11 $26.61 $64.19 $64.42 $25.5
Low 52 $7.15 $33.05 $25.15 $53.72 $55.01 $22.69
Price vs. 52 Week High -70.85 % -9.94 % -3.83 % -16.56 % -16.59 % -11.02 %
Price vs. 52 Week Low 19.16 % 1.12 % 1.75 % -0.3 % -2.33 % 0 %
Total Return
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
1 Month Return -14.63 % -4.05 % -1.69 % -7.7 % -7.76 % -2.99 %
3 Month Return -56.26 % -3.19 % -1.43 % -7.69 % -7.7 % -4.78 %
6 Month Return -59.04 % -7.4 % -1.8 % -10.81 % -10.78 % -9.75 %
9 Month Return -63.43 % -3.97 % 1.19 % -7.01 % -6.99 % -8.56 %
YTD Return -51.97 % -2.45 % -0.35 % -6.79 % -6.78 % -2.2 %
1 Year Return 0 % 0 % 0.43 % 0 % 0 % -10.14 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Dividend Yield Percentage (TTM) - 2.12 % - 1.12 % 1.48 % 3.01 %
Dividend Paid and Capex Coverage Ration (TTM) -26.96 % - -0.93 % - - 1.04 %
Dividend Per Share (TTM) - 0.71 % - 0.6 % 0.79 % 2.11 %
Payout Ratio (TTM) - - 35.03 % - - 60.98 %
Growth
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Asset Growth 102.63 % 2.56 %
Gross Profit Growth 100 % -
Revenue Growth - -
Revenue 3 Year - -
Revenue 5 Year - -
Revenue 10 Year - -
EBIT Growth -129.57 % -
Net Income Growth -125.11 % -
Net Income 3 Yeari Growth Per Share -613.12 % -
Net Income 5 Yeari Growth Per Share -613.12 % -
Net Income 10 Yeari Growth Per Share -613.12 % -
Operating Income Growth -129.57 % -
Operating Cash Flow Growth (CFG) -138.5 % -
Operating 3 Year CFG -1839.72 % -
Operating 5 Year CFG -1839.72 % -
Operating 10 Year CFG -1839.72 % -
EPS Growth -100 % -
EPS Diluted Growth -100 % -
Book Value Per Share 88.91 % -
Share Holder 3 Year Equity Growth Per Share 1418.98 % -
Share Holder 5 Year Equity Growth Per Share 1418.98 % -
Share Holder 10 Year Equity Growth Per Share 1418.98 % -
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -31.22 % -4.69 %
Free Cash Flow Growth -133.31 % -
Updated On 31 Dec 2024 31 Dec 2024
Profitability
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Gross Profit Margin TTM - 12.32 % 54.45 %
Return on Assets TTM -24.86 % 0.83 % 3.65 %
Return on Equity TTM -26.99 % 2.62 % 14.04 %
Return on Capital Employed TTM -27.13 % 0.03 % 4.55 %
Net Income Per EBT TTM 100 % 92.75 % 115.06 %
EBT Per Ebit TTM 94.28 % 2868.04 % 80.52 %
EBIT Per Revenue TTM - 2.23 % 30.23 %
Cash Flow To Debt Ratio TTM -4392.14 % -2.7 % 16.11 %
Receivables Turnover TTM - - 5.2
Payables Turnover TTM 0.18 - 1.62
Inventory Turnover TTM - - 5.1
Fixed Asset Turnover TTM - - 17.86 %
Asset Turnover TTM - 1.41 % 13.04 %
Operating Cash Flow Per Share TTM -0.34 -1.12 6.45
Free Cash Flow Per Share TTM -0.35 -1.12 2.31
Cash Per Share TTM 158.27 % 3693.13 % 72.29 %
Operating Cash Flow Sales Ratio TTM - -19.21 % 53.47 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.71 % 100 % 35.79 %
Cash Flow Coverage Ratios TTM -4392.14 % -2.7 % 16.11 %
Price To Free Cash Flows Ratio TTM -4.62 -22.95 30.37
Price To Operating Cash Flows Ratio TTM -25.35 -22.95 10.87
Price Cash Flow Ratio TTM -25.35 -22.95 10.87
Income Statement (TTM)
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Revenue $0B $45.83B $17.02B
Gross Profit $0B $5.65B $17.02B
Gross Profit Ratio 0% 12.32% 100%
EBITDA $-0.08B $1.02B $7.16B
Net Income $-0.08B $27.13B $4.54B
EPS Diluted -0.38 3.42 2.21
Balance Sheet (MRQ)
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Long Term Debt $0B $283.28B $0B
Total Liabilities $0.01B $2965.96B $129.28B
Total Equity $0.31B $3261.52B $50.5B
Total Investments $0.25B $0B $15.92B
Total Debt $0B $326.67B $9.95B
Total Assets $0.31B $3261.52B $190.14B
Cash Flow Statement (TTM)
RAPP CLBAX MER-PK CICAX FFICX NEE-PN
Net Income $-0.08B $27.13B $5.7B
Inventory $0B $0B $0B
Dividends Paid $0B $-9.5B $-4.24B
Operating Cash Flow $-0.06B $-8.81B $13.26B
Capital Expenditure $-0B $0B $-8.51B
Related Stocks
Ticker Name Price
AAACX Alpha Alternative Assets Fund 6.41
AAC-WT Ares Acquisition Corporation Re 0.63
AACQU Artius Acquisition Inc. 11.05
AADEX American Beacon Large Cap Value R5 25.61
AAIDX Axonic Alternative Income Fund 20.46
AAIN Arlington Asset Investment Corp 23.5
AAQC-WT 0.0057
AARTX Stone Ridge Trust VIII 10.54
ABRTX ABR DYNAMIC BLEND EQUITY & VOLATILITY FUND - INVESTOR SHARES 10.04
ACCNX American Century Core Plus Fd Investor Cl 9.24
ACHR-WT 1.3911
ACRO-WT 0.0105
ADEX-WT Adit EdTech Acquisition Corp. R 0.084
ADILW Adial Pharmaceuticals, Inc. WT EXP 073123 0.0009
ADRA-WT Adara Acquisition Corp. 0.0488
AEMGX Acadian Emerging Markets Portfolio Investor Class 22.52
AEVA-WT Aeva Technologies, Inc. Redeema 0.0693
AFDVX Applied Finance Explorer fund Investor Class 19.8
AFJKR Aimei Health Technology Co., Ltd Right 0.36
AFTR-WT 0.0041
ETFs With Exposure to RAPP
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00665 181.21
VTI Vanguard Total Stock Market Index Fund 0 248.53
IBB iShares Biotechnology ETF 0.01917 117.06
SCHB Schwab U.S. Broad Market ETF 0.000494021 19.47
SCHA Schwab U.S. Small-Cap ETF 0.00451979 21.185
IWN iShares Russell 2000 Value ETF 0.00618 137.085
IWO iShares Russell 2000 Growth ETF 0.00769 232.04
VHT Vanguard Health Care Index Fund 0 245.13
BIB ProShares Ultra Nasdaq Biotechnology 0.0123051 40.41
VXF Vanguard Extended Market Index Fund 0 155.29
HDG ProShares Hedge Replication ETF 0.000901867 46.96
UWM ProShares Ultra Russell2000 0.00232343 27.32
VTHR Vanguard Russell 3000 Index Fund 0 223.2
IWC iShares Micro-Cap ETF 0.04653 101.12
URTY ProShares UltraPro Russell2000 0.00134063 25.12
VTWV Vanguard Russell 2000 Value Index Fund 0 121
ISCB iShares Morningstar Small-Cap ETF 0.00205 49.23
SBIO ALPS Medical Breakthroughs ETF 0.0031 24.955
VTWG Vanguard Russell 2000 Growth Index Fund 0 169.63
VTWO Vanguard Russell 2000 Index Fund 0 73.19
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 89.76
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 89.75
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 45.73
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 45.72
VBINX Vanguard Balanced Index Fund Investor Shares 0 45.73
BOUT Innovator IBD Breakout Opportunities ETF 1.72 32.55
IBBQ Invesco Nasdaq Biotechnology ETF 0.038 19.49
VTSAX Vanguard Total Stock Market Index Fund 0 128.49
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.03492 5.795
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 124.4
VITSX Vanguard Total Stock Market Index Fund 0 128.5
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.03492 5.808
IBRN iShares Neuroscience and Healthcare ETF 0.37352 20.945
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 124.41
USFM.L UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-dis 0 2469.25
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 129.64
USUE.DE UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-acc 0 32.09
AVSC Avantis U.S. Small Cap Equity ETF 0 43.88
VEMPX Vanguard Extended Market Index InstlPlus 0 306.98
USFMDN.MX UBS (Irl) ETF Public Limited Company - MSCI USA Select Factor Mix UCITS ETF 0 382
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 241.06
MNTL Tema Neuroscience and Mental Health ETF 0.15 21.09
RSSL Global X Funds 0.01 71.2
Unlock